[Screening for atherosclerosis: 2006 update].
In recent years, several screening tests for subclinical atherosclerosis have been developed. The aim of these tests is to be able to better target preventive therapies to patients at high cardiovascular risk. However, the validity of these screening tests has not been well established for wide use in clinical practice. Being aware of these tests results might also enhance patient motivation to change unhealthy behaviors, such as smoking. However, the effectiveness of such strategy has been poorly studied. Early therapy of atherosclerosis has not been shown to improve clinical outcomes yet. Moreover, potential harms of such screening, such as induced anxiety, have been poorly studied. Although promising, such screening should be validated by clinical trials before routine use in clinical practice.
Rodondi
Nicolas
N
Consultation de prévention cardiovasculaire, PMU, Lausanne. Nicolas.Rodondi@hospvd.ch
Auer
Reto
R
Cornuz
Jacques
J
Paccaud
Fred
F
D003324:Coronary Artery Disease / Q000175:diagnosis*; D006801:Humans; D008403:Mass Screening; D012307:Risk Factors